Authors:
RODRIGUEZROSADO R
GARCIASAMANIEGO J
PEREZOLMEDA M
SORIANO V
MUNOZ F
GONZALEZLAHOZ J
Citation: R. Rodriguezrosado et al., HEPATOTOXICITY AFTER INTRODUCTION OF HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY (HAART) IN HIV-INFECTED PATIENTS, Hepatology, 28(4), 1998, pp. 1088-1088
Authors:
GOMEZCANO M
SORIANO V
PEREZOLMEDA M
MACHUCA A
RODRIGUEZROSADO R
VALENCIA E
MORENO V
GUTIERREZ M
GONZALEZLAHOZ J
Citation: M. Gomezcano et al., LONG-TERM SUPPRESSION OF HIV REPLICATION IN PATIENTS WITH SUSTAINED BENEFIT ON ZIDOVUDINE MONOTHERAPY, AIDS, 12(8), 1998, pp. 964-966
Authors:
SORIANO V
CASTILLA J
GOMEZCANO M
HOLGUIN A
VILLALBA N
MAS A
GONZALEZLAHOZ J
Citation: V. Soriano et al., THE DECLINE IN CD4-LYMPHOCYTES AS A FUNCTION OF THE DURATION OF HIV-INFECTION, AGE AT SEROCONVERSION, AND VIRAL LOAD( T), The Journal of infection, 36(3), 1998, pp. 307-311
Citation: V. Soriano et al., DETECTION OF HTLV-II PROVIRAL SEQUENCES IN HIV-IMMUNOSUPPRESSED PATIENTS WITH HTLV INDETERMINATE SEROLOGICAL PATTERNS, The Journal of infection, 36(2), 1998, pp. 243-244
Authors:
SORIANO V
GOMEZCANO M
CASTILLA J
VILLALBA N
HOLGUIN A
BRAVO R
MAS A
PEREZLABAD ML
GONZALEZLAHOZ J
Citation: V. Soriano et al., INTERELATIONSHIP BETWEEN THE DURATION OF HIV-INFECTION, THE VIRAL LOAD AND THE CD4+ LYMPHOCYTE COUNT, Medicina Clinica, 110(14), 1998, pp. 529-531
Authors:
VAZQUEZ VS
MARTINEZECHEVARRIA RRR
JIMENEZNACHER I
ORTEGA EV
CELDA VM
GONZALEZLAHOZ J
Citation: Vs. Vazquez et al., EFFICACY AND TOLERANCE OF THE COMBINATION AZT, DDC AND SAQUINAVIR IN HIV-INFECTED PATIENTS, Revista Clinica Espanola, 198(9), 1998, pp. 634-635
Authors:
SORIANO V
RODRIGUEZROSADO R
SILVA T
GONZALEZLAHOZ J
Citation: V. Soriano et al., ADMISSIONS AND DECEASES IN AN HIV UNIT BEFORE AND AFTER PROTEASE INHIBITORS, Revista Clinica Espanola, 198(10), 1998, pp. 715-715
Authors:
MAS A
SORIANO V
GUTIERREZ M
FUMANAL F
ALONSO A
GONZALEZLAHOZ J
Citation: A. Mas et al., RELIABILITY OF A NEW RECOMBINANT IMMUNOBLOT ASSAY (RIBA HIV-1 HIV-2 SIA) AS A SUPPLEMENTAL (CONFIRMATORY) TEST FOR HIV-1 AND HIV-2 INFECTIONS/, Transfusion science, 18(1), 1997, pp. 63-69
Authors:
SORIANO V
GOMEZCANO M
CASTILLA J
LAGUNA F
GONZALEZLAHOZ J
Citation: V. Soriano et al., ADDITION OF LAMIVUDINE TO THE DRUG REGIMEN IN PATIENTS WITH ADVANCED HIV DISEASE ON NUCLEOSIDE THERAPY, European journal of clinical microbiology & infectious diseases, 16(6), 1997, pp. 477-479
Authors:
MEDRANO FJ
SORIANO V
CALDERON EJ
REY C
GUTIERREZ M
BRAVO R
LEAL M
GONZALEZLAHOZ J
LISSEN E
Citation: Fj. Medrano et al., SIGNIFICANCE OF INDETERMINATE REACTIVITY TO HUMAN T-CELL LYMPHOTROPICVIRUS IN WESTERN-BLOT-ANALYSIS OF INDIVIDUALS AT RISK, European journal of clinical microbiology & infectious diseases, 16(3), 1997, pp. 249-252
Authors:
SORIANO V
DIETRICH U
VILLALBA N
IMMELMANN A
GILAGUADO A
ECHEVARRIA S
CLOTET B
OCANA I
SANTAMARIA JM
BOUZA E
BARONA V
GATELL JM
GONZALEZLAHOZ J
Citation: V. Soriano et al., LACK OF EMERGENCE OF GENOTYPIC RESISTANCE TO STAVUDINE AFTER 2 YEARS OF MONOTHERAPY, AIDS, 11(5), 1997, pp. 696-697
Authors:
SORIANO V
GOMEZCANO M
ADRADOS M
CASTILLA J
VILLALBA N
LAGUNA F
GONZALEZLAHOZ J
Citation: V. Soriano et al., SHORT-TERM RESPONSE TO INDINAVIR IN PATIENTS WITH ADVANCED HIV DISEASE WITH PRIOR HEAVY EXPOSURE TO NUCLEOSIDE ANALOGS, AIDS, 11(3), 1997, pp. 391-392
Authors:
VILLALBA N
GOMEZCANO E
CASAS E
SORIANO V
VALENCIA E
GONZALEZLAHOZ J
Citation: N. Villalba et al., SAFETY AND EFFICACY OF 2 DIFFERENT TRIPLE-DRUG COMBINATIONS IN WHICH EITHER LAMIVUDINE OR DIDANOSINE WERE ADMINISTERED WITH STAVUDINE PLUS INDINAVIR, AIDS, 11(15), 1997, pp. 1896-1897
Authors:
SORIANO V
MARTIN R
DELROMERO J
HEREDIA A
DIETRICH U
MAS A
ADRADOS M
MARTINEZ P
HEWLETT I
GONZALEZLAHOZ J
Citation: V. Soriano et al., OUTCOME IN A COHORT OF LONG-TERM NONPROGRESSORS IN MADRID - VIROLOGICAL AND IMMUNOLOGICAL FINDINGS, AIDS, 11(1), 1997, pp. 123-124
Authors:
SORIANO V
GARCIALERMA G
BRAVO R
GARCIASAMANIEGO J
GONZALEZ J
CASTRO A
GONZALEZLAHOZ J
Citation: V. Soriano et al., LACK OF ANTIRETROVIRAL EFFECT OF ALPHA-INTERFERON IN HIV-INFECTED PATIENTS TREATED FOR CHRONIC HEPATITIS-C, The Journal of infection, 35(3), 1997, pp. 319-320
Authors:
SORIANO V
GOMEZCANO M
MAS A
VILLALBA N
CASTILLA J
ADRADOS M
LAGUNA F
POLO R
GONZALEZLAHOZ J
Citation: V. Soriano et al., QUANTITATION OF VIREMIA IN PATIENTS INFEC TED WITH HUMAN-IMMUNODEFICIENCY-VIRUS WITH DIFFERENT DEGREES OF IMMUNOSUPPRESSION, Revista Clinica Espanola, 197(12), 1997, pp. 810-813
Authors:
HERNANDEZ PLM
ORTEGA MEV
DERIVERA JMPS
VAZQUEZ VS
GONZALEZLAHOZ J
FERNANDEZ FA
GAY DL
GOMEZ FP
SILES JC
MARTINEZ MM
GARCIA JG
RODRIGUEZ JJV
Citation: Plm. Hernandez et al., INFECTION WITH THE HUMAN-IMMUNODEFICIENCY -VIRUS (HIV) IN THE GERIATRIC AGE - EPIDEMIOLOGIC AND CLINICAL-STUDY IN 42 PATIENTS IN THE MADRIDCOMMUNITY, Revista Clinica Espanola, 197(10), 1997, pp. 684-689
Authors:
VALLEJO A
FERRANTE P
SORIANO V
CALABRO ML
MANCUSO R
HEREDIA A
MANNELLA E
FAVERO A
GARCIASAIZ A
CHIECOBIANCHI L
GONZALEZLAHOZ J
HEWLETT IK
Citation: A. Vallejo et al., NUCLEOTIDE-SEQUENCE AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM ANALYSIS OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II (HTLV-II) IN SOUTHERN EUROPE - EVIDENCE FOR THE HTLV-IIA AND HTLV-IIB SUBTYPES, Journal of acquired immune deficiency syndromes and human retrovirology, 13(4), 1996, pp. 384-391
Authors:
GATELL JM
GONZALEZLAHOZ J
CLOTET B
ANTUNES F
KASPAROVA L
GILAGUADO A
SABALLS P
SANTAMARIA JM
PODZAMCZER D
MIRO JM
JOU A
VERDEJO J
DOROANA M
THOMIS J
BAQUERO F
DEWIT S
LEDEINE JM
GOMEZ JJG
BUIRA E
POLO R
SORIANO V
BACHES MC
GIMENEZ GS
LAVILLA P
CONZALEZ J
RODRIGUEZ MCG
DUPLA ML
CARVALHO C
FORTE M
CALDEIRA L
DUARTE N
ZUBERO Z
TEIRA R
MUNOZ J
SANTIN AC
GUDIOL F
IRIBARREN JA
ARRIZABALAGA J
ARRONDO FR
GARDE C
VIERNA SE
ECHANOVE JA
SANZ JS
CEPEDA CS
OCHAITA JC
FERNANDEZCRUZ E
ZABAY JM
TRUJILLO FG
ALDEGUER JL
RODRIGO JL
VAZQUEZ JMM
NOVAL JM
ELIAS MJP
RUEDA LB
DEMORA PM
LOPEZ AA
DONATE JMH
ESTANY C
FERRER MG
DOMENECH MAS
Citation: Jm. Gatell et al., SWITCHING FROM ZIDOVUDINE TO DIDANOSINE IN PATIENTS WITH SYMPTOMATIC HIV-INFECTION AND DISEASE PROGRESSION, Journal of acquired immune deficiency syndromes and human retrovirology, 12(3), 1996, pp. 249-258
Authors:
DOWNS AM
DEVINCENZI I
COSTIGLIOLA P
RICCHI E
CHIODO F
ROUMELIOTOU A
PAPAEVANGELOU G
COUTINHO RA
VANHAASTRECHT HJA
BRETTLE R
ROBERTSON R
KRAUS M
HECKMANN W
SARACCO A
SACCO OL
JOHNSON AM
VANDENBRUAENE M
GOEMAN J
CARDOSO J
SOBEL A
GONZALEZLAHOZ J
ANDRESMEDINA R
CASABONA J
TOR J
ANCELLEPARK RA
BRUNET JB
Citation: Am. Downs et al., PROBABILITY OF HETEROSEXUAL TRANSMISSION OF HIV - RELATIONSHIP TO THENUMBER OF UNPROTECTED SEXUAL CONTACTS, Journal of acquired immune deficiency syndromes and human retrovirology, 11(4), 1996, pp. 388-395
Authors:
SORIANO V
GARCIASAMANIEGO J
BRAVO R
GONZALEZ J
CASTRO A
CASTILLA J
MARTINEZODRIOZOLA P
COLMENERO M
CARBALLO E
SUAREZ D
RODRIGUEZPINERO FJ
MORENO A
DELROMERO J
PEDREIRA J
GONZALEZLAHOZ J
LOPEZCALVO S
LLIBRE JM
SANTAMARIA JM
GONZALEZANGLADA I
MARTINEZZAPICO R
VAZQUEZ JJ
MARTINEZVAZQUEZ JM
RODRIGUEZ C
GARCIA S
MARTIN R
BRU F
VICARIO JL
ARROYO E
COSIN J
ZABAY JM
MAS A
MUNOZ F
Citation: V. Soriano et al., INTERFERON-ALPHA FOR THE TREATMENT OF CHRONIC HEPATITIS-C IN PATIENTSINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 23(3), 1996, pp. 585-591
Authors:
SORIANO V
GUTIERREZ M
CABALLERO E
CILLA G
FERNANDEZ JL
AGUILERA A
TUSET C
DRONDA F
MARTIN AM
CARBALLO E
LOPEZ I
GONZALEZLAHOZ J
DELEJARAZU RO
EIROS JM
TOR J
MUGA R
PUJOL E
CALDERON E
LEAL M
MARTINEZZAPICO R
POZO F
DELROMERO J
RODRIGUEZ C
ULLOA F
PEREZTRALLERO E
BRAVO R
MAS A
GARCIALERMA G
PEREZLABAD ML
GOMEZCANO M
VILLALBA N
HEREDIA A
VALLEJO A
HEWLETT I
Citation: V. Soriano et al., EPIDEMIOLOGY OF HIV-2 INFECTION IN SPAIN, European journal of clinical microbiology & infectious diseases, 15(5), 1996, pp. 383-388
Authors:
SORIANO V
VALLEJO A
GUTIERREZ M
TUSET C
CILLA G
MARTINEZZAPICO R
DRONDA F
CABALLERO E
CALDERON E
AGUILERA A
MARTIN AM
LLIBRE J
DELROMERO J
DELEJARAZU R
ULLOA F
EIROS J
GONZALEZLAHOZ J
Citation: V. Soriano et al., EPIDEMIOLOGY OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-II (HTLV-II) INFECTION IN SPAIN, European journal of epidemiology, 12(6), 1996, pp. 625-629